awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42425704-509F2C74-9954-4508-A9AB-A8B7152BD134
Q42425704-509F2C74-9954-4508-A9AB-A8B7152BD134
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42425704-509F2C74-9954-4508-A9AB-A8B7152BD134
Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma.
P2860
Q42425704-509F2C74-9954-4508-A9AB-A8B7152BD134
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42425704-509F2C74-9954-4508-A9AB-A8B7152BD134
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8466a6593da30fd3cd19d8fc8959e5ef33e213b2
P2860
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.